Systemic Lupus Erythematosus – A Contemporary View of its Genetic Determination, Immunopathogenesis and Therapy
Authors:
M. Buc 1; J. Rovenský 2
Authors place of work:
Imunologický ústav Lekárskej fakulty UK, Bratislava
1; Národný ústav reumatických chorôb, Piešťany
2
Published in the journal:
Epidemiol. Mikrobiol. Imunol. 58, 2009, č. 1, s. 3-14
Summary
Systemic lupus erythematosus (SLE) is an organ non-specific autoimmune disorder, with multiple immunopathogenic mechanisms being implicated in its development. The most conspicuous feature of the disease is an exaggerated synthesis of various types of autoantibodies, followed by the formation of immune complexes that deposit in tissues and elicit an inflammatory response. Apart from antibodies, dendritic cells, T cells and cytokines are substantially involved in the pathogenesis of SLE and class I interferons seem to play a crucial role. SLE is a genetically determined disease. HLA system and complement system genes, apoptosis regulating genes and IgG Fc-gamma receptor genes are among the multiple genes implicated in SLE. The role of hormones, both estrogen and progesterone, in SLE activity has been reported. Some monoclonal antibodies have recently proved effective in the treatment of SLE.
Key words:
autoantibodies, HLA complex – complement – interferon signature – monoclonal antibodies – SLE – T cells.
Zdroje
1 . Abraham, L. J., Kroeger, K. M. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol, 1999, 66, 562-566.
2. Anolik, J. H., Campbell, D., Felgar, R. E., Young F. et al. The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheumatism, 2003, 48, 455-459.
3. Baechler, E. C., Gregersen, P. K., Behrens, T. W. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol, 2004, 416, 801-807.
4. Banchereau, J., Pascual, V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity, 2006, 25, 383-392.
5. Bijlsma, J. W., Straub, R. H., Masi, A. T., Lahita RG, Cutolo, M. Neuroendocrine immune mechanisms in rheumatic diseases. Trends Immunol, 2002, 23, 59-61.
6. Blanco, P., Palucka, A. K., Gill, M., Pascual, V., Banchereau. J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science, 2001, 294, 1540-1543.
7. Buc, M. Autoimunita a autoimunitné choroby. Bratislava: Veda, 2005, 491 s.
8. Buc, M. Imunológia. Bratislava: Veda, 2001, 434 s.
9. Carlsten, H., Holmdahl, R., Tarkowski, A. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice. Immunol, 1991, 73, 186-190.
10. Carroll, M. C. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol, 2004, 4, 825-831.
11. Crawford, K., Alper, C. A. Genetics of the complement system. Rev Immunogenet, 2000, 2, 323-338.
12. Crispin, J. C., Vargas, M. I., Alcocer-Varela, J. Immunoregulatory T cells in autoimmunity. Autoimmun Rev, 2004, 3, 45-51.
13. Dhaher, Y. Y., Greenstein, B. D., Khamashta, M. A., Hughes, G. R. Effects of oestradiol and the oestrogen antagonist Ici 182,780 on the delayed type hypersensitivity (DTH) index and on serum levels of IgM and IgG in ovariectomised Balb/C and MRL/Mp-Lpr/Lpr mice, a model of systemic lupus erythematosus (SLE). Autoimmunity, 2001, 33, 237-243.
14. Dorner, T., Chaoui, R., Feist, E., Goldner, B. et al. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block. J Autoimmun, 1995, 8, 675-684.
15. Dorner, T., Lipsky, P. E. Immunoglobulin variable-region gene usage in systemic autoimmune diseases. Arthritis and rheumatism, 2001, 44, 2715-2727.
16. Dostál, C. Systémový lupus erytematodes. In: Rovenský, J. Klinická reumatológia. Martin: Osveta, 2000, 275-301.
17. Dostál, C. Systémový lupus erytematosus a gravidita. In: Rovenský, J. Reumatologia v teórii a praxi. Martin: Osveta, 1998, 309-316.
18. Doyle, H. A., Yan, J., Liang, B., Mamula, M. J. Lupus autoantigens: their origins, forms, and presentation. Immunol Res, 2001, 24, 131-147.
19. Gillmore, J. D., Hutchinson, W. L., Herbert, J., Bybee, A. et al. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunol, 2004, 112, 255-264.
20. Harley, J. B., Moser, K. L., Gaffney, P. M., Behrens, T. W. The genetics of human systemic lupus erythematosus. Curr Opin Immunol, 1998, 10, 690-696.
21. Jara, L. J., Benitez, G., Medina, G. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev, 2008, 7, 251-255.
22. Jara, L. J., Vera-Lastra, O., Miranda, J. M., Alcala M., Alvarez-Nemegyei, J. Prolactin in human systemic lupus erythematosus. Lupus 2001, 10, 748‑756.
23. Katsiari, C. G., Tsokos, G. C. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus. Autoimmun Reviews, 2006, 5, 118-121.
24. Kotzin, B. L., West, S. G. Systemic lupus erythematosus. In Rich R. R. Clinical Immunology Principles and practice. Edinburg, New York, Philadelphia, St. Louis, Sydney, Toronto: Mosby, 2001, 60.61-60.24.
25. Larsson, M., Fonteneau, J. F., Bhardwaj, N. Dendritic cells resurrect antigens from dead cells. Trends Immunol, 2001, 22, 141-148.
26. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature, 2002, 416, 603-607.
27. Lipsky, P. E. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol, 2001, 2, 764-766.
28. Maloy, K. J., Powrie, F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001, 2, 816-822.
29. McMurray, R., Keisler, D., Kanucke, K., Izui, S., Walker, S. E. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol, 1991, 147, 3780-3787.
30. Nath, S. K., Kilpatrick, J., Harley, J. B. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol, 2004, 16, 794-800.
31. Nose, M., Nishihara, M., Kamogawa, J., Terada, M., Nakatsuru, S. Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci. Rev Immunogenet, 2000, 2, 154-164.
32. Odendahl, M., Jacobi, A., Hansen, A., Feist, E. et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol, 2000, 165, 5970-5979.
33. Raman, K., Mohan, C. Genetic underpinnings of autoimmunity lessons from studies in arthritis, diabetes, lupus and multiple sclerosis. Curr Opin Immunol, 2003, 15, 651-659.
34. Ramanujam, M., Davidson, A. BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled? Immunol Rev, 2008, 223, 156-174.
35. Rovenský, J. Klinická reumatológia. Martin: Osveta, 2000, 1048 s.
36. Scofield, R. H. Genetic knock out of 60kD Ro (or SSA), a common lupus autoantigen, induces lupus. Trends Immunol, 2004, 25, 1-3.
37. Shaw, T., Quan, J., Totoritis, M. C. B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience. Ann Rheum Dis, 2003, 62, Suppl. 2, 55-59.
38. Tenbrock, K., Juang, Y. T., Kyttaris, V. C., Tsokos, G. C. Altered signal transduction in SLE T cells. Rheumatol, 2007, 46, 1525-1530.
39. Teplitsky, V., Shoenfeld, Y., Tanay, A. The renin-angiotensin system in lupus: physiology, genes and practice, in animals and humans. Lupus, 2006, 15, 319-325.
40. Thome, M., Tschopp, J. Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol, 2001, 1, 50-58.
41. Tsao, B. P. The genetics of human systemic lupus erythematosus. Trends Immunol, 2003, 24, 595-602.
42. Tsokos, G. C., Nambiar, M. P., Tenbrock, K., Jung, Y. T. Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE. Trends Immunol, 2003, 24, 259-263.
43. Vidaver, R. Molecular and clinical evidence of the role of estrogen in lupus. Trends Immunol, 2002, 23, 229-230.
44. Whitacre, C. C. Sex differences in autoimmune disease. Nat Immunol, 2001, 2, 777-780.
45. Woof, J. M., Burton, D. R. Human antibody-Fc receptor interactions illuminated by crystal structures. Nat Rev Immunol, 2004, 4, 89-99.
Štítky
Hygiene and epidemiology Medical virology Clinical microbiologyČlánok vyšiel v časopise
Epidemiology, Microbiology, Immunology
2009 Číslo 1
Najčítanejšie v tomto čísle
- Systemic Lupus Erythematosus – A Contemporary View of its Genetic Determination, Immunopathogenesis and Therapy
- Prevalence and Characteristics of Salmonella in Selected Localities of the Czech Republic – Comparison of Epidemiological and Laboratory Data
- Comparison of Susceptibility of Spores of Bacillus subtilis and Czech Strains of Clostridium difficile to Disinfectants
- Molecular Biological and Phenotypical Characterization of Human Isolates of Salmonella Enterica Serovar Paratyphi B dT+ or Salmonella Java